# NGN Capital: portfolio, investments and team > NGN Capital is a vc firm based in United States. 21 investments on record, latest Sept 2015. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/ngn-capital (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # NGN Capital Last cheque observed Sep 2015. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Email VC firm Quiet Seed Series A Series B Ehealth Health Longevity Follow NGN Capital and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fngn-capital) Cheques on record **0%** of best year **0** **cheques in 12 months**, 21 on record Since the last cheque **4092** days **00** hrs **00** min **00** sec Median round **$20M** Rounds led **0 of 21** Sole investor **1 rounds** Exits **5 from the portfolio** Mostly in **United States, 81%** Pitch NGN Capital ## NGN Capital highlights - 01 21 rounds on record - 02 Mostly Series B and Series C: 62% of its rounds - 03 Sole investor in 1 rounds, median $6.6M - 04 5 exits from the portfolio ## What they do > The site lists 'Portfolio Companies' and 'Team' but does not explicitly describe its investment activities. From their own website - **Type:** VC firm (from a list, unverified) - **Cheque size:** Not stated - **Stages:** Seed Series A Series B Growth Pre-IPO - **Sectors:** Ehealth Health Longevity - **Based in:** New York, United States - **Cold pitches:** Not accepted ## The record Every round we can evidence, newest first **21 appearances** - **2015** 1 round - **Sept** **[Exosome Diagnostics](https://millionrounds.com/company/exosome-diagnostics)** Series B · US **$18M** With 4 others - **2014** 1 round - **Mar** **[Exosome Diagnostics](https://millionrounds.com/company/exosome-diagnostics)** Series B · US **$27M** With 4 others - **2012** 1 round - **Nov** **[Endosense](https://millionrounds.com/company/endosense)** Series C · CH · finsmes.com **$40M** With 7 others - **2010** 4 rounds - **Dec** **[Small Bone Innovations](https://millionrounds.com/company/small-bone-innovations)** Series F · US · finsmes.com **$15M** With 2 others - **Jul** **[Artisan Pharma](https://millionrounds.com/company/artisan-pharma)** Series C · US · masshightech.com **$3.0M** With 4 others - **May** **[Exosome Diagnostics](https://millionrounds.com/company/exosome-diagnostics)** Series A · US · exosomedx.com **$20M** With 1 other - **Mar** **[Artisan Pharma](https://millionrounds.com/company/artisan-pharma)** Series B · US · artisanpharma.net **$22M** With 3 others - **2009** 4 rounds - **Sept** **[BeneChill](https://millionrounds.com/company/benechill)** Series C · US · onbiovc.com **$14M** With 2 others - **Apr** **[Small Bone Innovations](https://millionrounds.com/company/small-bone-innovations)** Series D · US · totalsmallbone.com **$108M** With 4 others - **Apr** **[Aerovance](https://millionrounds.com/company/aerovance)** Venture · US · venturebeat.com **$38M** With 7 others - **Apr** **[Cerapedics](https://millionrounds.com/company/cerapedics)** Series B · US · devicespace.com **$15M** With 1 other - **2008** 2 rounds - **May** **[ACT Biotech](https://millionrounds.com/company/act-biotech)** Series A · US · sec.gov **$6.6M** Sole investor - **Jan** **[Small Bone Innovations](https://millionrounds.com/company/small-bone-innovations)** Series C · US · totalsmallbone.com **$36M** With 4 others - **2007** 3 rounds - **Mar** **[Nitec Pharma AG](https://millionrounds.com/company/nitec-pharma-ag)** Series B · CH **$26M** With 2 others - **Mar** **[Aerovance](https://millionrounds.com/company/aerovance)** Series C · US · deals.venturebeat.com **$60M** With 5 others - **Jan** **[Tigris Pharmaceuticals](https://millionrounds.com/company/tigris-pharmaceuticals)** Series B · US **$16M** With 2 others - **2006** 2 rounds - **Sept** **[Artisan Pharma](https://millionrounds.com/company/artisan-pharma)** Series A · US · artisanpharma.net **$39M** With 4 others - **Mar** **[EKOS Corporation](https://millionrounds.com/company/ekos-corporation)** Series C · US · ekoscorp.com **$26M** With 8 others - **2005** 2 rounds - **Feb** **[EKOS Corporation](https://millionrounds.com/company/ekos-corporation)** Series B · US · ekoscorp.com **$18M** With 3 others - **Feb** **[Jerini](https://millionrounds.com/company/jerini)** Venture · DE **$20M** With 4 others - **2004** 1 round - **Dec** **[Santhera Pharmaceuticals Holding](https://millionrounds.com/company/santhera-pharmaceuticals-holding)** Series A · CH **$19M** With 1 other An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **3 named** JR **John Richard Costantino** Manager i Form ADV KS **Kenneth Samuel Abramowitz** Manager i Form ADV PJ **Peter Johann** Manager i Form ADV We also hold **8** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What the register says From the firm's own filings with the SEC, which it must file accurately by law **$113M** gross assets of its funds Oct 2026 **Exempt** reporting adviser venture or small private funds - **Legal name:** NGN Capital LLC - **SEC number:** CRD 162938 ## Exits from the portfolio Companies it backed that were later bought or listed **5 in all** **[Small Bone Innovations](https://millionrounds.com/company/small-bone-innovations)** Bought by Stryker Corporation **$375M** Jun 2014 **[Endosense](https://millionrounds.com/company/endosense)** Bought by [St. Jude Medical](https://millionrounds.com/fund/st-jude-medical) **$170M** Aug 2013 **[EKOS Corporation](https://millionrounds.com/company/ekos-corporation)** Bought by [BTG](https://millionrounds.com/fund/btg) **$220M** May 2013 **[Artisan Pharma](https://millionrounds.com/company/artisan-pharma)** Bought by Asahi Kasei Pharma **Undisclosed** Nov 2011 **[Jerini](https://millionrounds.com/company/jerini)** Bought by [Shire](https://millionrounds.com/fund/shire) **$554M** Jul 2008 An exit counts when it came after the firm's first round in the company. From historical deal records. ## The cheque Seed Series A Series B Median round joined **$20M** the round, not its cheque Alone, median **$6.6M** Led 0 of 21 rounds **0%** - **Sole investor:** 1 rounds - **Last cheque:** Sept 2015 - **Exits:** 5 from the portfolio Rounds by stage said on their site - Series B said *7* - Series C *6* - Series A said *4* - Venture *2* - Series D *1* - Series F *1* - Seed said *-* Cheques by year Led Joined 2004 2015 Often in the room with - [3i Group](https://millionrounds.com/fund/3i-group) 3 - [Bio*One Capital](https://millionrounds.com/fund/bio-one-capital) 3 - [Forbion Capital Partners](https://millionrounds.com/fund/forbion-capital-partners) 3 - [Jafco Ventures](https://millionrounds.com/fund/jafco-ventures) 3 - [MedVenture Associates](https://millionrounds.com/fund/medventure-associates) 3 - [Alta Partners](https://millionrounds.com/fund/alta-partners) 2 **Pitching NGN Capital?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as NGN Capital. A count of rooms they were both in, not a relationship either has claimed. [**3i Group** Private equity **3** rounds together](https://millionrounds.com/fund/3i-group)[**Bio*One Capital** Corporate VC **3** rounds together](https://millionrounds.com/fund/bio-one-capital)[**Forbion Capital Partners** Private equity **3** rounds together](https://millionrounds.com/fund/forbion-capital-partners)[**Jafco Ventures** Growth equity **3** rounds together](https://millionrounds.com/fund/jafco-ventures)[**MedVenture Associates** VC firm **3** rounds together](https://millionrounds.com/fund/medventure-associates)[**Alta Partners** VC firm **2** rounds together](https://millionrounds.com/fund/alta-partners)[**Apax Partners** Private equity **2** rounds together](https://millionrounds.com/fund/apax-partners)[**Arcus Ventures** VC firm **2** rounds together](https://millionrounds.com/fund/arcus-ventures)[**Burrill & Company** VC firm **2** rounds together](https://millionrounds.com/fund/burrill-and-company)[**Clarus Ventures** VC firm **2** rounds together](https://millionrounds.com/fund/blackstone)[**EGS Healthcare Capital Partners** VC firm **2** rounds together](https://millionrounds.com/fund/egs-healthcare-capital-partners)[**Lehman Brothers** Hedge fund **2** rounds together](https://millionrounds.com/fund/lehman-brothers) ## Quick answers about NGN Capital ### What does NGN Capital invest in? NGN Capital invests most often at Series B and Series C (62% of the rounds on record), in sectors such as Ehealth, Health and Longevity. ### How active is NGN Capital? 21 investments on record, 0 of them in the last 12 months. The most recent was in Sept 2015. ### How big are NGN Capital's cheques? The median round it joins is $20M. ### Does NGN Capital lead rounds? Rarely, if at all: none of its 21 investments on record names it as the lead. ### Where does NGN Capital invest? Most of the companies it backs are in the United States (81%) and Switzerland (14%). ### Is NGN Capital investing now? No investments in the last 12 months; the latest was in Sept 2015. ### Who does NGN Capital invest alongside? Most often 3i Group (3 rounds together), Bio*One Capital (3 rounds together) and Forbion Capital Partners (3 rounds together). ### What kind of investor is NGN Capital? NGN Capital is a VC firm based in New York, United States. ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=ngn-capital) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=ngn-capital)